Sino Biopharmaceutical Ltd ADR (SBHMY)
Sino Biopharmaceutical Limited ADR is a depositary receipt representing common stock of Sino Biopharmaceutical Limited, which is listed on OTC Markets under OTC-SBHM.Y. The underlying issuer is an investment holding company and pharmaceutical group based in Wan Chai, Hong Kong, with operations focused on research and development in the People’s Republic of China. Its business is organized across modernised Chinese medicines and chemical medicines, investment, and other activities. The company markets a range of prescription medicines in areas such as oncology, liver disease, respiratory care, and surgery/analgesia, and it also advances additional drug candidates in these therapeutic fields. Beyond its core pharmaceutical operations, Sino Biopharmaceutical is involved in long-term investments and healthcare and hospital-related businesses.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Payment Date | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-SBHM.Y
|
$19.62
|
34.9% Upside
|
Undervalued
|
Not available
|
Not available
|
Great
|
October 9, 2026
|
1.7%
|
November 30, 2026
|
37.2x
|
2.7x
|
2.6x
|
13.249 B
|
10.596 B
|
14.3%
|
49.0%
|
6.9
|
64.1%
|
